Skip to content

Clinical trials

Overweight trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Brazil Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20081
20095
20102
20112
20123
20131
20143
20151
20161
20174
20186
20192
20201
20216
20224
20239
20245
20258
202620

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting20
Unknown status10
Active, not recruiting7
Not yet recruiting6
Withdrawn3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company20
Novo Nordisk A/S6
University of Sao Paulo6
Hospital de Clinicas de Porto Alegre5
Federal University of Health Science of Porto Alegre4
Federal University of Minas Gerais4
University of Sao Paulo General Hospital4
Amgen2
AstraZeneca2
Eurofarma Laboratorios S.A.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight87
Obesity81
Diabetes Mellitus, Type 211
Diabetes Mellitus6
Nutrition Disorders5
Weight Loss5
Sleep Apnea, Obstructive4
Insulin Resistance3
Prediabetic State3
Diabetes Mellitus, Type 12

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.